BSE Live
Mar 04, 16:01Prev. Close
62.57
Open Price
61.95
Bid Price (Qty.)
61.01 (50)
Offer Price (Qty.)
62.99 (33)
NSE Live
Mar 04, 15:58Prev. Close
62.63
Open Price
63.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
61.80 (44)
| Cash Flow of Brooks Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -13.51 | -14.95 | -17.53 | 2.48 | 10.69 | |
| Net CashFlow From Operating Activities | -9.39 | -5.05 | -6.18 | 9.56 | 8.12 | |
| Net Cash Used In Investing Activities | -2.33 | 1.12 | -5.14 | -16.80 | -13.56 | |
| Net Cash Used From Financing Activities | 9.61 | 5.78 | 11.82 | 7.01 | 4.32 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.10 | 1.85 | 0.51 | -0.23 | -1.12 | |
| Cash And Cash Equivalents Begin of Year | 2.50 | 0.65 | 0.14 | 0.37 | 1.49 | |
| Cash And Cash Equivalents End Of Year | 0.40 | 2.49 | 0.65 | 0.14 | 0.37 |
18.02.2026
Brooks Labs Consolidated December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
18.02.2026
Brooks Labs Consolidated December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
10.02.2026
Brooks Labs Standalone December 2025 Net Sales at Rs 16.57 crore, down 56.91% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y